☆ 4.8 Article

A CD8+ T cell-associated immune gene panel for prediction of the prognosis and immunotherapeutic effect of melanoma

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Medicine, Research & Experimental

IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer

Yan-Jie Chen et al.

Summary: This study found that the expression of IRF-2 was downregulated in gastric cancer tissues and was negatively correlated with the prognoses of gastric cancer patients. IRF-2 inhibits tumor growth by regulating the transcription of AMER-1 and the Wnt/β-catenin signaling pathway.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Medicine, Research & Experimental

IRF2-induced Claudin-7 suppresses cell proliferation, invasion and migration of oral squamous cell carcinoma

Xin Li et al.

Summary: This study found that CLDN7 expression is low in OSCC tissues and that overexpression of CLDN7 inhibits the proliferation, invasion, and migration of OSCC cells. IRF2 was found to bind to the CLDN7 promoter and regulate its expression, also affecting the functions of OSCC cells.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2022)

Add to Collection

Review Immunology

Tissue-specific tregs in cancer metastasis: opportunities for precision immunotherapy

Laura A. Huppert et al.

Summary: Advancements in immuno-oncology have led to the development of immunotherapies for metastatic cancer patients, providing long-term treatment responses but with infrequent cures. Recent research indicates that tumors in certain organ sites may exhibit unique response patterns to immunotherapy and could reduce antitumor immunity in distant tumors, possibly due to the activation of tissue-specific immune tolerogenic mechanisms.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers

Taku Fujimura

Summary: Tumor-infiltrating leukocytes (TILs) play a crucial role in immunotherapy using ICIs, highlighting the significance of evaluating the characteristics of tumor-associated cells in predicting the efficacy of immune checkpoint inhibitors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Nanoscience & Nanotechnology

Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy

Christine E. Boone et al.

Summary: Cancer immunotherapy, particularly immune checkpoint therapy, has shown significant clinical efficacy in some patients, but many do not respond to treatment or develop resistance and toxicity over time. Combination therapy with nanomedicine is a promising approach to overcome these limitations and enhance antitumor immunity. Nanoparticles can protect and control drug delivery, modulate the immune response, and serve as multifunctional platforms for cancer treatment in combination with immunotherapy.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2022)

Add to Collection

Review Nanoscience & Nanotechnology

Dendrimers for cancer immunotherapy: Avidity-based drug delivery vehicles for effective anti-tumor immune response

Piper A. Rawding et al.

Summary: Cancer immunotherapy utilizes the patient's immune system to treat cancer, but currently, it is only effective in a small subset of patients. Nanoparticles have been used as carriers for immunotherapeutic drugs, showing robust anti-tumor effects.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2022)

Add to Collection

Review Immunology

Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma

Valentin Benboubker et al.

Summary: Immunotherapies targeting negative immune checkpoints have been approved for treating various cancers, but resistance remains a major issue, especially in metastatic melanoma. Non-genetic alterations in cancer cells contribute to therapy resistance and immune evasion. Understanding the phenotypic reprogramming of melanoma cells can lead to new therapeutic strategies for improving outcomes in this aggressive cancer.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Immunology

Networks of CD8+ T Cell Response Activation in Melanoma and Vitiligo

Keitaro Fukuda

Summary: This article discusses the important role of MSA-specific CD8(+) T cells in the treatment outcomes of melanoma and vitiligo, and explores the key targets for enhancing the efficacy of current therapies and future immunotherapeutic approaches.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Oncology

ZEB1 transcription factor promotes immune escape in melanoma

Maud Plaschka et al.

Summary: This study reveals that ZEB1 expression in melanoma cells is associated with decreased CD8(+) T cell infiltration, leading to tumor immune evasion and resistance to immune checkpoint blockade. ZEB1 directly represses the secretion of T cell-attracting chemokines, such as CXCL10, and targeting ZEB1 may enhance the efficacy of immunotherapy in melanoma.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Review Chemistry, Medicinal

Reinvigorating exhausted CD8+cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy

Md Amir Hossain et al.

Summary: Immunotherapy has revolutionized cancer treatment in recent years, but many patients still exhibit limited responses to treatment strategies. Much attention is being given to targeting exhausted CD8(+)T cells to develop new immunotherapeutic approaches. Intrinsic and extrinsic mechanisms governing CD8(+)T-cell exhaustion are being explored to overcome limitations in treatment.

MEDICINAL RESEARCH REVIEWS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Progress and challenges of immunotherapy in triple-negative breast cancer

Yinxing Zhu et al.

Summary: The article discusses the relevance of TNBC and immunotherapy, summarizing the current progress in targeting different immune checkpoints in TNBC treatment and potential predictive biomarkers.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective

Sijia Gu et al.

Summary: The article summarizes the current application of immunotherapy in cancer treatment, focusing on the importance and potential clinical application prospects of tumor-infiltrated B cells in anti-tumor immunity.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Add to Collection

Review Dermatology

UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color A Systematic Review

Fabiana C. P. S. Lopes et al.

Summary: The systematic review revealed a weak association between UV exposure and melanoma in skin of color, with most studies not supporting UV protection for melanoma prevention. However, the evidence quality is moderate to low, necessitating further research to fully elucidate this association.

JAMA DERMATOLOGY (2021)

Add to Collection

Article Immunology

A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients

Chuan Li et al.

Summary: Single-cell transcriptomics revealed a subset of CD8 T cells with high oxidative phosphorylation in melanoma patients, which correlated with immune checkpoint inhibitor resistance. A predictive model based on transcriptomic profiles of these cells accurately distinguished responders from nonresponders, offering potential as a new target for improving outcomes in melanoma patients.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Article Immunology

Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis an Immunotherapy Outcome

Kexin Yan et al.

Summary: A prognostic risk assessment model was established for M2-related coexpressed genes in melanoma, with NOTCH3, DBN1, KDELC2, and STAB1 identified as essential genes promoting M2 macrophage infiltration. These genes are involved in antigen treatment and presentation, chemokine, cytokine, T cell receptor pathway, and IFN-gamma pathway. The model showed good prognostic ability and may provide candidate biomarkers for melanoma treatment and monitoring.

JOURNAL OF IMMUNOLOGY RESEARCH (2021)

Add to Collection

Review Oncology

Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy

Iris Lodewijk et al.

Summary: Epigenetic alterations in immune cells within the tumor microenvironment play a crucial role in shaping an immunosuppressive environment for cancer growth, potentially hindering the success of immunotherapy. Modulating epigenetics in combination with immunotherapy may present a promising therapeutic option to enhance treatment efficacy.

CLINICAL EPIGENETICS (2021)

Add to Collection

Article Oncology

Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients

Brigitte Dreno et al.

Summary: The study demonstrated the feasibility and safety of using Melan-A and MELOE-1 specific T cells for ACT in metastatic melanoma patients, but the clinical efficacy can be further enhanced by selecting highly reactive T cells based on PD-1 and TIGIT co-expression and combining with ICI such as anti-PD-1.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Add to Collection

Article Oncology

Intratumour microbiome associated with the infiltration of cytotoxic CD8+T cells and patient survival in cutaneous melanoma

Gongjian Zhu et al.

Summary: This study revealed that cutaneous melanoma patients with low levels of CD8+ T cells have shorter survival times, while the Lachnoclostridium genus in intratumour bacteria showed a positive association with infiltrating CD8+ T cells and was beneficial for patient survival. Manipulating the intratumour gut microbiome may improve patient outcomes during immunotherapy.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances

Strahil Strashilov et al.

Summary: Melanoma arises from malignant transformations of melanocytes and can occur in various parts of the body. The incidence and morbidity of cutaneous melanoma are on the rise globally, with Australia and New Zealand being leaders in this trend.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Oncology

IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin

Yarong Guo et al.

Summary: IRF2 promotes proliferation, inhibits apoptosis, and increases lenvatinib resistance of HCC cells by regulating fl-catenin expression. The expression of fl-catenin and IRF2 is positively correlated in HCC tissues. Inhibiting fl-catenin effectively abrogates lenvatinib resistance caused by lenvatinib treatment. Targeting IRF2 may improve the therapeutic effect of lenvatinib on HCC.

TRANSLATIONAL ONCOLOGY (2021)

Add to Collection

Review Immunology

Single-Cell TCR and Transcriptome Analysis: An Indispensable Tool for Studying T-Cell Biology and Cancer Immunotherapy

Anna Pasetto et al.

Summary: T cells are essential in immune responses and cancer immunotherapy. Single-cell sequencing techniques have enabled scientists to study T cells at a deeper level, including T-cell receptor and transcriptome analysis. These techniques also aid in the identification of T-cell neoantigens, advancing T-cell mediated cancer therapy.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Oncology

Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients

Biao Huang et al.

CANCER CELL INTERNATIONAL (2020)

Add to Collection

Article Oncology

FAM83H overexpression predicts worse prognosis and correlates with less CD8+ T cells infiltration and Ras-PI3K-Akt-mTOR signaling pathway in pancreatic cancer

H. Zhuang et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2020)

Add to Collection

Review Genetics & Heredity

Deciphering the Roles of IFITM1 in Tumors

Renba Liang et al.

MOLECULAR DIAGNOSIS & THERAPY (2020)

Add to Collection

Article Oncology

Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer

Yujie Zhang et al.

BMC CANCER (2020)

Add to Collection

Article Biochemistry & Molecular Biology

GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway

Shuye Yu et al.

ONCOGENE (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside

Darleny Y. Lizardo et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Add to Collection

Article Oncology

SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery

Siwen Hu-Lieskovan et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Add to Collection

Article Immunology

Induction of Progenitor Exhausted Tissue-Resident Memory CD8+ T Cells Upon Salmonella Typhi Porins Adjuvant Immunization Correlates With Melanoma Control and Anti-PD-1 Immunotherapy Cooperation

Ricardo A. Leon-Letelier et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The Influence of Tumor Microenvironment on Immune Escape of Melanoma

Aleksandra Simiczyjew et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Oncology

Zebrafish modeling reveals that SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment

Elena Gomez-Abenza et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Medicine, General & Internal

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

J. Larkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Review Oncology

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma

M. Oliva et al.

ANNALS OF ONCOLOGY (2019)

Add to Collection

Article Medicine, Research & Experimental

Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity

Chien-Chun Steven Pai et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Add to Collection

Article Multidisciplinary Sciences

Molecular cloning, GTP recognition mechanism and tissue-specific expression profiling of myxovirus resistance (Mx) protein in Labeo rohita (Hamilton) after Poly I: C induction

Basanta Kumar Das et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Cell Biology

Rsad2 is necessary for mouse dendritic cell maturation via the IRF7-mediated signaling pathway

Ji-Su Jang et al.

CELL DEATH & DISEASE (2018)

Add to Collection

Review Oncology

The immune contexture in cancer prognosis and treatment

Wolf H. Fridman et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

J. D. Wolchok et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Article Cell Biology

MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer

Chen Liang et al.

CELL DEATH & DISEASE (2017)

Add to Collection

Article Oncology

PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors

Hojabr Kakavand et al.

CLINICAL CANCER RESEARCH (2017)

Add to Collection

Article Multidisciplinary Sciences

Epigenetic regulation of OAS2 shows disease-specific DNA methylation profiles at individual CpG sites

Xiaolian Gu et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Editorial Material Oncology

PD-L1 Testing in Cancer Challenges in Companion Diagnostic Development

Aaron R. Hansen et al.

JAMA ONCOLOGY (2016)

Add to Collection

Review Biochemistry & Molecular Biology

Mx GTPases: dynamin-like antiviral machines of innate immunity

Otto Haller et al.

TRENDS IN MICROBIOLOGY (2015)

Add to Collection

Article Oncology

Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response

Patricio Godoy et al.

BREAST CANCER (2014)

Add to Collection

Article Immunology

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

Gabriela Bindea et al.

IMMUNITY (2013)

Add to Collection

Review Immunology

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

A Mantovani et al.

TRENDS IN IMMUNOLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.